Log in
Enquire now

List of SBIR/STTR awards granted to LPATH THERAPEUTICS, INC.

List of SBIR/STTR awards granted to LPATH THERAPEUTICS, INC.
List of SBIR/STTR awards granted to Fieldmetrics Inc.
List of SBIR/STTR awards granted to TLC Precision Wafer Technology, Inc.
List of SBIR/STTR awards granted to MBF Bioscience
List of LensVector patents
List of funding rounds for Intellifusion
where
SBIR/STTR Award Recipient
is
‌
LPATH THERAPEUTICS, INC.
Name
Description
SBIR/STTR Award Recipient
Government Agency
Government Branch
Award Type
Contract Number (US Government)
Award Phase
Award Amount (USD)
Date Awarded
Official Website
‌
LPATH THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to LPATH THERAPEUTICS, INC. for $139,523.0 USD from the U.S. Department of Health & Human Services.

‌
LPATH THERAPEUTICS, INC.
SBIR
1R43CA132395-01A2
Phase I
139,523
sbir.gov/content/development-therapeutic-monoclonal-antibody-bioactive-lipid-lysophospha-0
‌
LPATH THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to LPATH THERAPEUTICS, INC. for $152,553.0 USD from the U.S. Department of Health & Human Services.

‌
LPATH THERAPEUTICS, INC.
SBIR
1R43HL075906-01
Phase I
152,553
sbir.gov/content/role-sphingolipids-cardiac-ischemia-0
‌
LPATH THERAPEUTICS, INC. SBIR Phase II Award,

A SBIR Phase II contract was awarded to LPATH THERAPEUTICS, INC. for $3,000,000.0 USD from the U.S. Department of Health & Human Services.

‌
LPATH THERAPEUTICS, INC.
SBIR
2R44CA110298-04
Phase II
3,000,000
sbir.gov/content/commercialization-asonep-treatment-cancer-0
‌
LPATH THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to LPATH THERAPEUTICS, INC. for $399,709.0 USD from the U.S. Department of Health & Human Services.

‌
LPATH THERAPEUTICS, INC.
SBIR
1R43AI058367-01
Phase I
399,709
sbir.gov/content/therapeutic-approach-sulfur-mustard-exposure-0
‌
LPATH THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to LPATH THERAPEUTICS, INC. for $151,601.0 USD from the U.S. Department of Health & Human Services.

‌
LPATH THERAPEUTICS, INC.
SBIR
1R43HL075910-01
Phase I
151,601
sbir.gov/content/sphingolipids-markers-cardiac-ischemia-0
‌
LPATH THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to LPATH THERAPEUTICS, INC. for $152,724.0 USD from the U.S. Department of Health & Human Services.

‌
LPATH THERAPEUTICS, INC.
SBIR
1R43GM088956-01
Phase I
152,724
sbir.gov/content/structure-based-design-humanized-monoclonal-antibodies-recognize-bioactiv-0
‌
LPATH THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to LPATH THERAPEUTICS, INC. for $155,353.0 USD from the U.S. Department of Health & Human Services.

‌
LPATH THERAPEUTICS, INC.
SBIR
1R43CA110298-01
Phase I
155,353
sbir.gov/content/anti-sphingolipid-antibodies-treatment-cancer-0
‌
LPATH THERAPEUTICS, INC. SBIR Phase II Award,

A SBIR Phase II contract was awarded to LPATH THERAPEUTICS, INC. for $1,107,210.0 USD from the U.S. Department of Health & Human Services.

‌
LPATH THERAPEUTICS, INC.
SBIR
2R44CA110298-02
Phase II
1,107,210
sbir.gov/content/anti-sphingolipid-antibodies-treatment-cancer-2
‌
LPATH THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to LPATH THERAPEUTICS, INC. for $223,988.0 USD from the U.S. Department of Health & Human Services.

‌
LPATH THERAPEUTICS, INC.
SBIR
1R44NS087641-01
Phase I
223,988
sbir.gov/node/706487
‌
LPATH THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to LPATH THERAPEUTICS, INC. for $145,230.0 USD from the U.S. Department of Health & Human Services.

‌
LPATH THERAPEUTICS, INC.
SBIR
1R43DK098829-01
Phase I
145,230
sbir.gov/node/677808
‌
LPATH THERAPEUTICS, INC. SBIR Phase I Award,

A SBIR Phase I contract was awarded to LPATH THERAPEUTICS, INC. for $125,844.0 USD from the U.S. Department of Health & Human Services.

‌
LPATH THERAPEUTICS, INC.
SBIR
1R43EY018020-01
Phase I
125,844
sbir.gov/content/sphingomab-mitigates-multiple-pathologies-age-related-macular-degeneration-0
‌
LPATH THERAPEUTICS, INC. SBIR Phase II Award,

A SBIR Phase II contract was awarded to LPATH THERAPEUTICS, INC. for $1,418,280.0 USD from the U.S. Department of Health & Human Services.

‌
LPATH THERAPEUTICS, INC.
SBIR
2R44EY018020-02
Phase II
1,418,280
sbir.gov/content/sphingomab-mitigates-multiple-pathologies-age-related-macular-degeneration-2
12 results
0 selected
12 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us